Antibody testing for brain immunohistochemistry: Brain immunolabeling for the cannabinoid CB2 receptor

Journal of Neuroscience Methods

Volumn 216, Issue 2, 2013, Pages 87-95

  Baek, Jean Ha ^a   Darlington, Cynthia L ^a   Smith, Paul F ^a   Ashton, John C ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Brain immunohistochemistry; Cannabinoid; CB2 receptor; Hippocampus

Indexed keywords

CANNABINOID 2 RECEPTOR; EPITOPE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY LABELING; ANTIBODY SPECIFICITY; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; BRAIN; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, KNOCKOUT; NEURONS; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB2;

EID: 84878187331     PISSN: 01650270     EISSN: 1872678X     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2013.03.021     Document Type: Article

References (22)

1. Ashton J.C. The use of knockout mice to test the specificity of antibodies for cannabinoid receptors. Hippocampus 2012, 22:643-644.
2. Atwood B.K., Mackie K. CB2: a cannabinoid receptor with an identity crisis. Br J Pharmacol 2010, 160:467-479.
3. Buckley N.E., McCoy K.L., Mezey E., Bonner T., Zimmer A., Felder C.C., et al. Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. Eur J Pharmacol 2000, 396:141-149.
4. Bussolati G., Leonardo E. Technical pitfalls potentially affecting diagnoses in immunohistochemistry. J Clin Pathol 2008, 61:1184-1192.
5. Fernandez-Ruiz J., Romero J., Velasco G., Tolon R.M., Ramos J.A., Guzman M. Cannabinoid CB2 receptor: a new target for controlling neural cell survival?. Trends Pharmacol Sci 2007, 28:39-45.
6. Goldstein N.S., Hunter S., Forbes S., Odish E., Tehrani M. Estrogen receptor antibody incubation time and extent of immunoreactivity in invasive carcinoma of the breast: the importance of optimizing antibody avidity. Appl Immunohistochem Mol Morphol 2007, 15:203-207.
7. Gong J.P., Onaivi E.S., Ishiguro H., Liu Q.R., Tagliaferro P.A., Brusco A., et al. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res 2006, 1071:10-23.
8. Grimsey N.L., Goodfellow C.E., Scotter E.L., Dowie M.J., Glass M., Graham E.S. Specific detection of CB1 receptors: cannabinoid CB1 receptor antibodies are not all created equal!. J Neurosci Methods 2008, 171:78-86.
9. Hajos N., Katona I., Naiem S.S., MacKie K., Ledent C., Mody I., et al. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur J Neurosci 2000, 12:3239-3249.
10. Ibrahim M.M., Deng H., Zvonok A., Cockayne D.A., Kwan J., Mata H.P., et al. Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS. Proc Natl Acad Sci U S A 2003, 100:10529-10533.
11. Jelsing J., Larsen P.J., Vrang N. Identification of cannabinoid type 1 receptor expressing cocaine amphetamine-regulated transcript neurons in the rat hypothalamus and brainstem using in situ hybridization and immunohistochemistry. Neuroscience 2008, 154:641-652.
12. Lorincz A., Nusser Z. Specificity of immunoreactions: the importance of testing specificity in each method. J Neurosci 2008, 28:9083-9086.
13. Morgan N.H., Stanford I.M., Woodhall G.L. Functional CB2 type cannabinoid receptors at CNS synapses. Neuropharmacology 2009, 57:356-368.
14. Moser N., Mechawar N., Jones I., Gochberg-Sarver A., Orr-Urtreger A., Plomann M., et al. Evaluating the suitability of nicotinic acetylcholine receptor antibodies for standard immunodetection procedures. J Neurochem 2007, 102:479-492.
15. Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993, 365:61-65.
16. Rhodes K.J., Trimmer J.S. Antibodies as valuable neuroscience research tools versus reagents of mass distraction. J Neurosci 2006, 26:8017-8020.
17. Saper C.B., Sawchenko P.E. Magic peptides, magic antibodies: guidelines for appropriate controls for immunohistochemistry. J Comp Neurol 2003, 465:161-163.
18. Suarez J., Bermudez-Silva F.J., Mackie K., Ledent C., Zimmer A., Cravatt B.F., et al. Immunohistochemical description of the endogenous cannabinoid system in the rat cerebellum and functionally related nuclei. J Comp Neurol 2008, 509:400-421.
19. Suarez J., Llorente R., Romero-Zerbo S.Y., Mateos B., Bermudez-Silva F.J., de Fonseca F.R., et al. Early maternal deprivation induces gender-dependent changes on the expression of hippocampal CB(1) and CB(2) cannabinoid receptors of neonatal rats. Hippocampus 2009, 19:623-632.
20. Van Sickle M.D., Duncan M., Kingsley P.J., Mouihate A., Urbani P., Mackie K., et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 2005, 310:329-332.
21. Xi Z.X., Peng X.Q., Li X., Song R., Zhang H.Y., Liu Q.R., et al. Brain cannabinoid CB(2) receptors modulate cocaine's actions in mice. Nat Neurosci 2011, 14:1160-1166.
22. Zimmer A., Zimmer A.M., Hohmann A.G., Herkenham M., Bonner T.I. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci U S A 1999, 96:5780-5785.